Dr. Sabine Hazan, MD

Speaker Title: A Case Report on Late-Stage Oropharyngeal Squamous Cell Carcinoma improved by refloralization

Biography:  Dr. Sabine Hazan sought a career in medicine and was accepted to medical school based on outstanding research on obesity conducted as an undergraduate. She completed her residency at the University of Miami during the peak of the HIV epidemic, treating extremely ill patients at Jackson Memorial Hospital and in the local jail. After completing her residency, Dr. Hazan became the first woman gastroenterology fellow at the University of Florida. There, she completed a year of research and presented her findings at the American College of Gastroenterology (ACG) Meeting. It was at that moment that she was approached by the esteemed Dr. Neil Stollman. He told her that the future of medicine lies in the microbiome. Following her fellowship, Dr. Hazan returned to Montreal and opened a practice in upstate New York. Then she moved to Southern California, and she started her own clinical trial company, Ventura Clinical Trials, and has been Principal Investigator and Sub-Investigator in over 150 clinical trials. Many of these trials were for Clostridioides difficile infection (CDI). When her patients with C. diff did not respond to traditional therapies, she resorted to treatment via fecal microbiota transplant (FMT), which she later coined Refloralization™. In 2019, she founded Progenabiome, LLC, a genetic research lab whose interest is to understand the clinical implications of the microbiome. Our broad array of specialties allows us to look beyond fecal transplant (Refloralization™) to examine other fields of medicine in which dysbiosis could be the culprit of disease.